Probiotic Blend for Menopausal Symptoms and Quality of Life Improvement
Gyntima Menopause
+ Placebo
Signs and Symptoms
+ Pathological Conditions, Signs and Symptoms
+ Hot Flashes
Prevention Study
Summary
Study start date: September 10, 2024
Actual date on which the first participant was enrolled.This clinical trial is designed to explore whether a specific combination of probiotics can help alleviate symptoms experienced by women during menopause, a time when hormone levels naturally decrease. The study focuses on peri- and post-menopausal women, aiming to see if these probiotics can enhance the presence of active oestrogens in the blood, which might ease menopause-related symptoms. This research is important because many women seek natural ways to manage menopause symptoms, and finding effective probiotic solutions could offer a new, non-hormonal option for improving their quality of life. Participants in the study will receive either the probiotic blend or a placebo, ensuring that the results can be accurately measured without bias. The probiotics are taken orally, as part of the daily routine. The study does not specify exact measurements or outcomes it will monitor, but it usually involves checking changes in symptoms and overall quality of life. By observing any differences between the group taking the probiotics and the placebo group, researchers aim to determine the effectiveness and safety of this probiotic treatment for menopause symptoms.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.140 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 42 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location